Rachesky Mark H MD 的 Form 4 申報
Lionsgate Studios Corp.（LION），2026/7/10 申報
- 申報編號
- 0001193125-26-301179
- 申報時間
- 2026/7/10 20:00 ET
- 交易日
- 2026/7/8
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 12 筆非衍生性交易。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Rachesky Mark H MDCIK 0001194368 | 董事、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/7/8 | Common Shares | S賣出處分 | −1,469,450 | –F27 | – | 0 | 間接 | |
| 2026/7/8 | Common Shares | S賣出處分 | −3,701,988 | –F28 | – | 0 | 間接 | |
| 2026/7/8 | Common Shares | S賣出處分 | −25,173,882 | –F29 | – | 0 | 間接 | |
| 2026/7/8 | Common Shares | P買進取得 | +797,526 | –F27 | – | 797,526 | 間接 | |
| 2026/7/8 | Common Shares | P買進取得 | +1,916,271 | –F28 | – | 1,916,271 | 間接 | |
| 2026/7/8 | Common Shares | P買進取得 | +11,154,680 | –F29 | – | 11,154,680 | 間接 | |
| 2026/7/8 | Common Shares | P買進取得 | +671,924 | –F27 | – | 671,924 | 間接 | |
| 2026/7/8 | Common Shares | S賣出處分 | −499,765 | –F30 | – | 172,159 | 間接 | |
| 2026/7/8 | Common Shares | P買進取得 | +499,765 | –F30 | – | 499,765 | 間接 | |
| 2026/7/8 | Common Shares | P買進取得 | +15,804,919 | –F28,F29 | – | 15,804,919 | 間接 | |
| 2026/7/8 | Common Shares | S賣出處分 | −11,755,412 | –F31 | – | 4,049,507 | 間接 | |
| 2026/7/8 | Common Shares | P買進取得 | +11,755,412 | –F31 | – | 11,755,412 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F27
In connection with that certain continuation fund transaction, as further described in Amendment No. 2 to Schedule 13D filed by the certain of the reporting persons on July 9, 2026 (the "CV Transaction"), Institutional Partners II contributed the Common Shares held for its account to Sun II and LION Holdco A, in exchange for limited partnership interests in Sun II and limited partnership interests and certain other interests in LION Holdco A. Dr. Rachesky's indirect pecuniary interest in the Common Shares may be deemed to have increased as a result of the transactions described in footnotes (27), (28) and (29) due to Dr. Rachesky and certain of his affiliated entities being investors in an entity that is a limited partner in LION Holdco A and LION Holdco B.
表 I 有 3 筆交易的價格引用這則附註。
- F28
In connection with the CV Transaction, Institutional Partners IIA contributed the Common Shares held for its account to Sun IIA and LION Holdco B, in exchange for limited partnership interests in Sun IIA and limited partnership interests and certain other interests in LION Holdco B.
表 I 有 3 筆交易的價格引用這則附註。
- F29
In connection with the CV Transaction, Institutional Partners III contributed the Common Shares held for its account to Sun III and LION Holdco B, in exchange for limited partnership interests in Sun III and limited partnership interests and certain other interests in LION Holdco B.
表 I 有 3 筆交易的價格引用這則附註。
- F30
In further connection with the CV Transaction, immediately following the contribution of Common Shares from Institutional Partners II, LION Holdco A, as the sole limited partner of LION SubHoldco A, contributed certain of the Common Shares held for its account to LION SubHoldco A.
表 I 有 2 筆交易的價格引用這則附註。
- F31
In connection with the CV Transaction, immediately following the contribution of Common Shares from Institutional Partners IIA and Institutional Partners III, LION Holdco B, as the sole limited partner of LION SubHoldco B, contributed certain of the Common Shares held for its account to LION SubHoldco B.
表 I 有 2 筆交易的價格引用這則附註。